Discovery and characterization of a mammalian amyloid disaggregation activity
Open Access
- 24 March 2010
- journal article
- research article
- Published by Wiley in Protein Science
- Vol. 19 (4), 836-846
- https://doi.org/10.1002/pro.363
Abstract
The formation of amyloid, a cross‐β‐sheet fibrillar aggregate, is associated with a variety of aging‐associated degenerative diseases. Herein, we report the existence of a mammalian amyloid disaggregase activity that is present in all tissues and cell types tested. Homogenates from mammalian tissues and cell lines are able to disaggregate amyloid fibrils composed of amyloid β (Aβ)1–40 or the 8 kDa plasma gelsolin fragment. The mammalian disaggregase activity is sensitive to proteinase K digestion and can be uncoupled from proteolysis activity using a protease inhibitor cocktail. Amyloid disaggregation and proteolysis activities are remarkably resistant to changes in temperature and pH. Identification and manipulation of the proteins responsible for the amyloid disaggregation/degradation activities offers the possibility of ameliorating aggregation‐associated diseases.Keywords
Funding Information
- NIH (AG031097)
- Proteostasis Therapeutics, Inc., Skaggs Institute for Chemical Biology, Lita Annenberg Hazen Foundation, Bruce Ford and Anne Smith Bundy Foundation
This publication has 49 references indexed in Scilit:
- Site-specific modification of Alzheimer's peptides by cholesterol oxidation products enhances aggregation energetics and neurotoxicityProceedings of the National Academy of Sciences, 2009
- A kinetic assessment of the C. elegans amyloid disaggregation activity enables uncoupling of disassembly and proteolysisProtein Science, 2009
- A general strategy for the bacterial expression of amyloidogenic peptides using BCL‐XL‐1/2 fusionsProtein Science, 2009
- Secretion of amyloidogenic gelsolin progressively compromises protein homeostasis leading to the intracellular aggregation of proteinsProceedings of the National Academy of Sciences, 2009
- Chaperonin TRiC Promotes the Assembly of polyQ Expansion Proteins into Nontoxic OligomersMolecular Cell, 2006
- Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseasesNature Cell Biology, 2004
- Folding proteins in fatal waysNature, 2003
- Therapeutic approaches to protein-misfolding diseasesNature, 2003
- Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolutionJournal of Molecular Medicine, 2003
- Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseasesNature, 2002